Delivery Order SPE2DB20D3505-SPE2DB23FT5P3

Award Date 1/13/23
Potential Completion Date 1/17/23
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order with a Firm Fixed Price of $1,796.37 for the supply of OFLOXACIN 0.3% EAR DROPS 5ML. The contract is awarded by the Medical Supply Chain, which is an alternate name for the Defense Logistics Agency (DLA), a civilian agency. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation is for the delivery of Ofloxacin 0.3% ear drops. The $3,047.55 firm fixed price delivery order contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is not designated as a set-aside. The contract is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,945.69, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 16, 2021. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, with a ceiling value of $1,933.30. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, a pharmaceutical product, with a ceiling value of $3,486.18. The contract was awarded on September 27, 2022, with a completion date of September 28, 2022, and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award is for the delivery of Ofloxacin 0.3% ear drops in 10 mL bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,157.34 and a period of performance ending on December 28, 2021. The contract was awarded on December 27, 2021 and does not have a set-aside...
This federal contract award is for the delivery of Ofloxacin 0.3% ear drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2022, with a ceiling value of $3,509.19 and a completion date of December 12, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (the parent company of...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,640.84 contract is for the delivery of Ofloxacin 0.3% ear drops, 5ml, to support DLA Troop Support Medical programs and facilities. No set aside designation was used. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,161.78 firm fixed price delivery order is for NEOMYCIN-POLYMYXIN-HC EAR SUSPENSION, a medical product used to treat ear infections. The contract has a completion date of May 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,005.20 firm fixed-price delivery order is for the medical product "CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML" and has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB23FT5P3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML. The $5,469.25 firm fixed-price delivery order has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. Additionally, AmerisourceBergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 9:42 AM